NCT03525873View on ClinicalTrials.gov

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Methylphenidate

Given PO

OTHER

Physical Activity

Participate in physical activity

OTHER

Placebo

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER